home / stock / xbi / xbi news


XBI News and Press, SPDR Series Trust S&P Biotech From 01/02/26

Stock Information

Company Name: SPDR Series Trust S&P Biotech
Stock Symbol: XBI
Market: NYSE

Menu

Get XBI Alerts

News, Short Squeeze, Breakout and More Instantly...

XBI - Biotech: Time For A Pause To Start 2026

2026-01-02 06:52:42 ET The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the ad...

XBI - 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood

2025-12-29 13:00:00 ET ... Read the full article on Seeking Alpha For further details see: 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood

XBI - State Street® SPDR® S&P® Biotech ETF declares $0.4066 dividend

2025-12-22 09:15:07 ET More on State Street® SPDR® S&P® Biotech ETF XBI: Biotech Funding Condition Recovery Could Be Overdue XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component 3 Reasons To Be Optimistic Around Biotech ...

XBI - 2025 Performance Review And Future Strategy

2025-12-22 08:30:48 ET Now that 2025 is nearing its close and the holidays are upon us, I want to wish readers a joyous year-end holiday season. You likely have festivities to attend (and I do too), but as the year winds down I wanted to close with my annual performance review. Busi...

XBI - Key Takeaways From Equity Earnings Calls: Q3 2025

2025-12-19 03:10:00 ET By Frank Coughlin A clear story has emerged from the third quarter earnings season - one of divergence. We are seeing a market split between companies benefiting from major secular growth trends and those navigating more traditional economic cycles.... ...

XBI - LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF

2025-12-17 12:29:56 ET Fast Facts About the Direxion Daily S&P Biotech Bull 3X ETF Read the full article on Seeking Alpha For further details see: LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF

XBI - Why An Investment Process Matters, Especially In Volatile Markets

2025-12-06 01:25:00 ET ... Read the full article on Seeking Alpha For further details see: Why An Investment Process Matters, Especially In Volatile Markets

XBI - 3 Potential Mid-Cap Biotech Buyout Targets In 2026

2025-12-03 18:22:57 ET The biotech sector got off to an inauspicious start to December in trading on Monday. The iShares Biotechnology ETF ( IBB ) was off 2.14% yesterday while the State Street® SPDR® S&P® Biotech ETF ( XBI ) dropped 2.69% on Monday. This ...

XBI - SEC warns Direxion, ProShares, and Tidal, stalling new leveraged ETF launches

2025-12-03 01:00:01 ET More on ETFs UDOW: Benefits And Risks Of The 3x Leveraged Dow Jones ETF SDS: Benefits And Risks Of The -2x S&P 500 Leveraged ETF Powell could stay on as Fed governor after giving up chair role, like former chief Eccles Q3 earnings s...

XBI - December 2025 Perspective

2025-12-02 03:18:00 ET November offered a reminder that even in a market defined by powerful structural themes, the path forward is seldom linear. US equities ended the month mixed, with the S&P 500 and Dow posting modest gains, while the Nasdaq registered its first monthly decline ...

Previous 10 Next 10